Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Capital Leases (2016 - 2018)

Amphastar Pharmaceuticals has reported Capital Leases over the past 6 years, most recently at $1.1 million for Q4 2018.

  • For Q4 2018, Capital Leases fell 22.25% year-over-year to $1.1 million; the TTM value through Dec 2018 reached $1.1 million, down 22.25%, while the annual FY2018 figure was $1.1 million, 22.25% down from the prior year.
  • Capital Leases for Q4 2018 was $1.1 million at Amphastar Pharmaceuticals, down from $1.1 million in the prior quarter.
  • Over five years, Capital Leases peaked at $1.9 million in Q2 2016 and troughed at $802000.0 in Q4 2015.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2018 define the central range for Capital Leases.
  • Biggest five-year swings in Capital Leases: surged 101.25% in 2016 and later fell 22.25% in 2018.
  • Year by year, Capital Leases stood at $1.0 million in 2014, then decreased by 21.53% to $802000.0 in 2015, then soared by 101.25% to $1.6 million in 2016, then dropped by 15.92% to $1.4 million in 2017, then fell by 22.25% to $1.1 million in 2018.
  • Business Quant data shows Capital Leases for AMPH at $1.1 million in Q4 2018, $1.1 million in Q3 2018, and $1.2 million in Q2 2018.